| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |